Deeter Investments »

Context Therapeutics shares owned by Deeter Investments

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Deeter Investments from 13F filings

Historical chart of Deeter Investments investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Deeter Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Deeter Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $147k 100k 1.47

More positions owned by Deeter Investments

Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Micron Technology (MU)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Adobe Systems Incorporated (ADBE)
Quanta Services (PWR)
Vale S A Sponsored Ads (VALE)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Ge Vernova (GEV)
Ishares Tr China Lg-cap Etf (FXI)
Alibaba Group Hldg Sponsored Ads (BABA)
Western Digital (WDC)
Nextera Energy (NEE)

View all positions for Deeter Investments

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics